NASDAQ:TRUP - Trupanion Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $98.60
Forecasted Upside: -13.36 %
Number of Analysts: 6
Breakdown:
0 Sell Ratings
3 Hold Ratings
3 Buy Ratings
0 Strong Buy Ratings

^$113.81 As of 07/27/2021 01:00 AM ET

▲ +0.26 (0.23%)

1 month | 3 months | 12 months

Get New Trupanion Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for TRUP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TRUP

^$98.60

▼ -13.36% Downside Potential

This price target is based on 6 analysts offering 12 month price targets for Trupanion in the last 3 months. The average price target is $98.60, with a high forecast of $150.00 and a low forecast of $43.00. The average price target represents a -13.36% upside from the last price of $113.81.

Current Consensus is Buy

The current consensus among 6 investment analysts is to buy stock in Trupanion. This rating has held steady since January 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations Description Skip Past Price Target Consensus Chart

0 strong buy ratings
1 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

2/4/2020

0 strong buy ratings
3 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

5/4/2020

0 strong buy ratings
3 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

8/2/2020

0 strong buy ratings
3 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

10/31/2020

0 strong buy ratings
3 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

1/29/2021

0 strong buy ratings
4 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

4/29/2021

0 strong buy ratings
3 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

6/28/2021

0 strong buy ratings
3 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

7/28/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/5/2021	Evercore ISI	Initiated Coverage	Outperform	$100.00	High
2/11/2021	Lake Street Capital	Boost Price Target	Buy	$85.00 ➝ $150.00	Low
2/11/2021	Canaccord Genuity	Boost Price Target	Buy	$140.00 ➝ $150.00	Low
11/2/2020	Canaccord Genuity	Boost Price Target	Buy	$88.00 ➝ $95.00	High
10/30/2020	Lake Street Capital	Boost Price Target		$67.00 ➝ $85.00	High
8/10/2020	Guggenheim	Downgrade	Buy ➝ Neutral		Low
8/5/2020	Canaccord Genuity	Boost Price Target	Buy	$58.00 ➝ $62.00	High
8/5/2020	Lake Street Capital	Boost Price Target	Positive ➝ Buy	$50.00 ➝ $67.00	High
8/5/2020	Northland Securities	Downgrade	Outperform ➝ Market Perform	$42.00 ➝ $50.00	High
7/30/2020	Stifel Nicolaus	Boost Price Target	Hold	$33.00 ➝ $43.00	Low
6/25/2020	Northland Securities	Initiated Coverage	Buy	$42.00	Medium
6/15/2020	Royal Bank of Canada	Reiterated Rating	Buy	$40.00	High
6/9/2020	Northland Securities	Initiated Coverage	Buy	$42.00	Low
5/1/2020	Lake Street Capital	Reiterated Rating	Buy	$50.00	Low
5/1/2020	Royal Bank of Canada	Boost Price Target	Outperform	$39.00 ➝ $40.00	High
5/1/2020	Northland Securities	Reiterated Rating	Buy	$35.00	High
4/27/2020	Royal Bank of Canada	Reiterated Rating	Buy	$39.00	High
4/8/2020	Royal Bank of Canada	Reiterated Rating	Buy	$39.00	High
4/6/2020	Northland Securities	Reiterated Rating	Buy	$35.00	High
3/2/2020	Canaccord Genuity	Reiterated Rating	Buy	$44.00	High
2/14/2020	Lake Street Capital	Boost Price Target	Buy	$46.00 ➝ $50.00	Low
2/14/2020	Canaccord Genuity	Reiterated Rating	Buy	$44.00	High
2/14/2020	Raymond James	Downgrade	Outperform ➝ Market Perform		High
1/8/2020	Stifel Nicolaus	Downgrade	Buy ➝ Hold	$32.00 ➝ $38.00	High
11/18/2019	Guggenheim	Boost Price Target	Buy	$35.00 ➝ $36.00	Low
11/6/2019	Northland Securities	Reiterated Rating	Buy	$40.00	High
10/11/2019	Craig Hallum	Set Price Target	Hold	$20.00	Low
8/16/2019	Craig Hallum	Downgrade	Buy ➝ Hold	$29.00	High
7/31/2019	Royal Bank of Canada	Set Price Target	Buy	$38.00	Low
7/31/2019	Northland Securities	Reiterated Rating	Buy	$40.00	High
5/23/2019	Guggenheim	Initiated Coverage	Buy ➝ Buy	$35.00	High
5/14/2019	Northland Securities	Initiated Coverage	Buy	$40.00	High
11/13/2018	Canaccord Genuity	Reiterated Rating	Buy	$43.00	High
10/2/2018	CL King	Upgrade	Neutral ➝ Buy		Low
9/6/2018	Raymond James	Initiated Coverage	Outperform ➝ Outperform	$46.00	High
8/3/2018	Lake Street Capital	Reiterated Rating	Buy	$41.00 ➝ $46.00	Medium
8/3/2018	Cowen	Boost Price Target	Outperform ➝ Positive	$41.00 ➝ $47.00	Medium
8/3/2018	Royal Bank of Canada	Boost Price Target	Outperform	$44.00	Medium
8/3/2018	Stifel Nicolaus	Boost Price Target	Buy ➝ Buy	$40.00 ➝ $43.00	Medium
8/3/2018	Canaccord Genuity	Boost Price Target	Buy ➝ Buy	$40.00 ➝ $46.00	Medium
7/19/2018	Craig Hallum	Initiated Coverage	Buy	$55.00	High
7/10/2018	Stifel Nicolaus	Boost Price Target	Buy ➝ Buy	$34.00 ➝ $40.00	Low
5/2/2018	Canaccord Genuity	Reiterated Rating	Buy	$40.00	Medium
2/14/2018	Lake Street Capital	Boost Price Target	Buy ➝ Buy	$32.00 ➝ $41.00	High
2/14/2018	Cowen	Reiterated Rating	Outperform	$32.00 ➝ $38.00	High
2/14/2018	Stifel Nicolaus	Reiterated Rating	Buy ➝ Buy	$33.00 ➝ $34.00	High
2/8/2018	Northland Securities	Reiterated Rating	Buy	$38.00	High
11/21/2017	CL King	Initiated Coverage	Neutral		N/A
10/31/2017	Canaccord Genuity	Reiterated Rating	Buy	$29.00 ➝ $35.00	N/A
8/2/2017	Canaccord Genuity	Boost Price Target	Buy	$28.00 ➝ $29.00	Medium
8/2/2017	Cowen	Reiterated Rating	Outperform	$19.00 ➝ $28.00	High
8/2/2017	Stifel Nicolaus	Reiterated Rating	Buy ➝ Buy	$18.00 ➝ $24.00	High
8/2/2017	Royal Bank of Canada	Boost Price Target	Outperform ➝ Outperform	$19.00 ➝ $26.00	High
7/14/2017	Cowen	Reiterated Rating	Buy	$19.00	Low
7/6/2017	Northland Securities	Set Price Target	Buy	$23.00	Low
5/26/2017	Northland Securities	Initiated Coverage	Outperform ➝ Outperform	$22.75	High
11/3/2016	Royal Bank of Canada	Reiterated Rating	Buy	$18.00	N/A
9/20/2016	Royal Bank of Canada	Set Price Target	Buy	$18.00	N/A
8/4/2016	Canaccord Genuity	Reiterated Rating	Buy	$19.00	N/A
8/3/2016	Royal Bank of Canada	Reiterated Rating	Outperform	$14.00 ➝ $18.00	N/A
8/3/2016	Stifel Nicolaus	Boost Price Target	Buy	$17.00 ➝ $20.00	N/A

(Data available from 7/28/2016 forward)

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment involves in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members and contracts include multiple pets. The company was founded by Darryl Rawlings in January 2000 and is headquartered in Seattle, WA.

Today's Range

Now: $113.81

$111.01

$114.16

50 Day Range

MA: $102.47

$75.84

$120.29

52 Week Range

Now: $113.81

$48.83

$126.53

Volume

229,492 shs

Average Volume

374,089 shs

Market Capitalization

$4.56 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91

Frequently Asked Questions

What sell-side analysts currently cover shares of Trupanion?

The following Wall Street sell-side analysts have issued research reports on Trupanion in the last twelve months: Canaccord Genuity, Evercore ISI, Guggenheim, Lake Street Capital, Northland Securities, Stifel Nicolaus, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for TRUP.

What is the current price target for Trupanion?

5 Wall Street analysts have set twelve-month price targets for Trupanion in the last year. Their average twelve-month price target is $98.60, suggesting a possible downside of 13.4%. Canaccord Genuity has the highest price target set, predicting TRUP will reach $150.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $43.00 for Trupanion in the next year.
View the latest price targets for TRUP.

What is the current consensus analyst rating for Trupanion?

Trupanion currently has 3 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TRUP will outperform the market and that investors should add to their positions of Trupanion.
View the latest ratings for TRUP.

What other companies compete with Trupanion?

Other companies that are similar to Trupanion include Molina Healthcare, Bright Health Group, Oscar Health, Alignment Healthcare, Clover Health Investments and Advanzeon Solutions.

How do I contact Trupanion's investor relations team?

Trupanion's physical mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider's listed phone number is (888) 733-2685 and its investor relations email address is [email protected] The official website for Trupanion is www.trupanion.com.